Refining the treatment of follicular lymphoma (Q37280919)

19 August 2017

1 reference

title

Refining the treatment of follicular lymphoma (English)

1 reference

19 August 2017

6

Wyndham Wilson

1 reference

19 August 2017

Christian Buske

1

1 reference

19 August 2017

Christian Gisselbrecht

2

1 reference

19 August 2017

John Gribben

3

1 reference

19 August 2017

Tony Letai

4

1 reference

19 August 2017

Peter McLaughlin

5

1 reference

19 August 2017

publication date

1 January 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

49 Suppl 1

1 reference

19 August 2017

page(s)

18-26

1 reference

New treatment options have changed the survival of patients with follicular lymphoma

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Rituximab maintenance therapy: a step forward in follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Follicular lymphoma international prognostic index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Primary cutaneous follicular lymphoma: a clinicopathologic and molecular study of 16 cases in support of a distinct entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Programmed anuclear cell death delimits platelet life span.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Rituximab Added to First-Line Mitoxantrone, Chlorambucil, and Prednisolone Chemotherapy Followed by Interferon Maintenance Prolongs Survival in Patients With Advanced Follicular Lymphoma: An East German Study Group Hematology and Oncology Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311409

10.1080/10428190802311409

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference